Amgen Announces Results Of Phase 3 Study Of Enbrel Dosed Once Weekly Read more about Amgen Announces Results Of Phase 3 Study Of Enbrel Dosed Once Weekly
Data From Study Shows Aranesp Dosed Every Other Week More Cost-Effective Than Epoetin Alfa For Treating Anemia In Chemotherapy Patients Read more about Data From Study Shows Aranesp Dosed Every Other Week More Cost-Effective Than Epoetin Alfa For Treating Anemia In Chemotherapy Patients
Amgen Submits Data To FDA Supporting Once-Weekly Dosing Of Enbrel Read more about Amgen Submits Data To FDA Supporting Once-Weekly Dosing Of Enbrel
Court Dismisses Amgen Reimbursement Challenge Read more about Court Dismisses Amgen Reimbursement Challenge
Landmark Trial Will Evaluate the Impact of Treating Anemia on Cardiovascular Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes Read more about Landmark Trial Will Evaluate the Impact of Treating Anemia on Cardiovascular Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes
Multimedia Available: Landmark Trial to Link Reduction in Cardiovascular Risk With Treatment of Anemia in Diabetics With Chronic Kidney Disease Read more about Multimedia Available: Landmark Trial to Link Reduction in Cardiovascular Risk With Treatment of Anemia in Diabetics With Chronic Kidney Disease
Amgen Commences Exchange Offer for Its Outstanding Liquid Yield Option Notes Due 2032 Read more about Amgen Commences Exchange Offer for Its Outstanding Liquid Yield Option Notes Due 2032
Amgen Announces Webcast of First Quarter Financial Results Read more about Amgen Announces Webcast of First Quarter Financial Results
Amgen Announces Results of Its Repurchase of Tendered Liquid Yield Option Notes Due 2032 Read more about Amgen Announces Results of Its Repurchase of Tendered Liquid Yield Option Notes Due 2032
Phase 3 Study Published in The Journal of Clinical Oncology Shows First-Cycle Administration of Neulasta Significantly Lowers Incidence of Neutropenia with Related Fever and Hospitalization Read more about Phase 3 Study Published in The Journal of Clinical Oncology Shows First-Cycle Administration of Neulasta Significantly Lowers Incidence of Neutropenia with Related Fever and Hospitalization
